(cache)NCBI Blast:ref|NZ_JACOEC010000070.1|

Save Search

Search Parameters
Search parameter name	Search parameter value
Program	blastn
Word size	28
Expect value	0.05
Hitlist size	100
Match/Mismatch scores	1,-2
Gapcosts	0,2.5
Low Complexity Filter	Yes
Filter string	L;m;
Genetic Code	1

Database
Database parameter name	Database parameter value
Posted date	Jan 22, 2025 12:59 PM
Number of letters	28,243,478,142
Number of sequences	48,926,134
Entrez query	Includes: Excludes: None

Karlin-Altschul statistics
Params	Ungapped	Gapped
Lambda	1.33271	1.28
K	0.620991	0.46
H	1.12409	0.85

Results Statistics
Results Statistics parameter name	Results Statistics parameter value
Length adjustment	32
Effective length of query	513
Effective length of database	26677841854
Effective search space	13685732871102
Effective search space used	13685732871102

Job Title

ref|NZ_JACOEC010000070.1| ...

RID

T77AJWCX016 Search expires on 01-25 21:01 pm

Download All

Results for

Program

BLASTN

Citation

Database

pat

See details

Query ID

NZ_JACOEC010000070.1

Description

Klebsiella sp. Kpp NODE_70_length_545_cov_1.895299, whole genome shotgun sequence ...

Molecule type

dna

Query Length

545

Other reports

Distance tree of results MSA viewer

Filter Results

Descriptions

select all
100 sequences selected

, Reading indexes 1-5, displaying indexes 1-5, Reading indexes 6-10, displaying indexes 6-10

Sequences producing significant alignments:
Select for downloading or viewing reports	Description	Scientific Name	Common Name	Taxid	Max Score	Total Score	Query Cover	E value	Per. Ident	Acc. Len	Accession
1Select seq PA271536.1	JP 2021511077-A/3: Influenza virus vaccines and uses thereof	synthetic construct	NA	32630	1007	1007	100%	0.0	100.00%	792	PA271536.1
2Select seq OF092927.1	KR 1020200113226-A/140: INFLUENZA VIRUS VACCINES AND USES THEREOF	synthetic construct	NA	32630	1007	1007	100%	0.0	100.00%	792	OF092927.1
3Select seq MP222602.1	Sequence 140 from Patent WO2019145310	synthetic construct	NA	32630	1007	1007	100%	0.0	100.00%	792	MP222602.1
4Select seq PA271537.1	JP 2021511077-A/4: Influenza virus vaccines and uses thereof	synthetic construct	NA	32630	996	996	100%	0.0	99.63%	792	PA271537.1
5Select seq OF092928.1	KR 1020200113226-A/141: INFLUENZA VIRUS VACCINES AND USES THEREOF	synthetic construct	NA	32630	996	996	100%	0.0	99.63%	792	OF092928.1
6Select seq MP222603.1	Sequence 141 from Patent WO2019145310	synthetic construct	NA	32630	996	996	100%	0.0	99.63%	792	MP222603.1
7Select seq PA271540.1	JP 2021511077-A/7: Influenza virus vaccines and uses thereof	synthetic construct	NA	32630	846	846	100%	0.0	94.68%	900	PA271540.1
8Select seq OF092931.1	KR 1020200113226-A/144: INFLUENZA VIRUS VACCINES AND USES THEREOF	synthetic construct	NA	32630	846	846	100%	0.0	94.68%	900	OF092931.1
9Select seq MP222606.1	Sequence 144 from Patent WO2019145310	synthetic construct	NA	32630	846	846	100%	0.0	94.68%	900	MP222606.1
10Select seq PA271541.1	JP 2021511077-A/8: Influenza virus vaccines and uses thereof	synthetic construct	NA	32630	841	841	100%	0.0	94.50%	900	PA271541.1
11Select seq OF092932.1	KR 1020200113226-A/145: INFLUENZA VIRUS VACCINES AND USES THEREOF	synthetic construct	NA	32630	841	841	100%	0.0	94.50%	900	OF092932.1
12Select seq MP222607.1	Sequence 145 from Patent WO2019145310	synthetic construct	NA	32630	841	841	100%	0.0	94.50%	900	MP222607.1
13Select seq PA271539.1	JP 2021511077-A/6: Influenza virus vaccines and uses thereof	synthetic construct	NA	32630	819	819	100%	0.0	93.76%	900	PA271539.1
14Select seq OF092930.1	KR 1020200113226-A/143: INFLUENZA VIRUS VACCINES AND USES THEREOF	synthetic construct	NA	32630	819	819	100%	0.0	93.76%	900	OF092930.1
15Select seq MP222605.1	Sequence 143 from Patent WO2019145310	synthetic construct	NA	32630	819	819	100%	0.0	93.76%	900	MP222605.1
16Select seq PA271534.1	JP 2021511077-A/1: Influenza virus vaccines and uses thereof	synthetic construct	NA	32630	736	736	100%	0.0	91.01%	792	PA271534.1
17Select seq OF092925.1	KR 1020200113226-A/138: INFLUENZA VIRUS VACCINES AND USES THEREOF	synthetic construct	NA	32630	736	736	100%	0.0	91.01%	792	OF092925.1
18Select seq MP222600.1	Sequence 138 from Patent WO2019145310	synthetic construct	NA	32630	736	736	100%	0.0	91.01%	792	MP222600.1
19Select seq PA271535.1	JP 2021511077-A/2: Influenza virus vaccines and uses thereof	synthetic construct	NA	32630	725	725	100%	0.0	90.66%	792	PA271535.1
20Select seq OF092926.1	KR 1020200113226-A/139: INFLUENZA VIRUS VACCINES AND USES THEREOF	synthetic construct	NA	32630	725	725	100%	0.0	90.66%	792	OF092926.1
21Select seq MP222601.1	Sequence 139 from Patent WO2019145310	synthetic construct	NA	32630	725	725	100%	0.0	90.66%	792	MP222601.1
22Select seq PA271538.1	JP 2021511077-A/5: Influenza virus vaccines and uses thereof	synthetic construct	NA	32630	664	664	100%	0.0	88.64%	900	PA271538.1
23Select seq OF092929.1	KR 1020200113226-A/142: INFLUENZA VIRUS VACCINES AND USES THEREOF	synthetic construct	NA	32630	664	664	100%	0.0	88.64%	900	OF092929.1
24Select seq MP222604.1	Sequence 142 from Patent WO2019145310	synthetic construct	NA	32630	664	664	100%	0.0	88.64%	900	MP222604.1
25Select seq MO632619.1	Sequence 89 from patent US 10526376			0	562	562	100%	6e-157	85.35%	840	MO632619.1
26Select seq MO632596.1	Sequence 17 from patent US 10526376			0	562	562	100%	6e-157	85.35%	870	MO632596.1
27Select seq MM028705.1	Sequence 89 from patent US 10086056			0	562	562	100%	6e-157	85.35%	840	MM028705.1
28Select seq MM028682.1	Sequence 17 from patent US 10086056			0	562	562	100%	6e-157	85.35%	870	MM028682.1
29Select seq LQ465429.1	Sequence 89 from Patent WO2016112921	unidentified influenza virus	NA	11309	562	562	100%	6e-157	85.35%	840	LQ465429.1
30Select seq LQ465357.1	Sequence 17 from Patent WO2016112921	unidentified influenza virus	NA	11309	562	562	100%	6e-157	85.35%	870	LQ465357.1
31Select seq PF151639.1	KR 1020230104068-A/28: UNIVERSAL INFLUENZA VACCINE USING NUCLEOSIDE-MODIFIELD MRNA	synthetic construct	NA	32630	532	532	100%	5e-148	84.30%	804	PF151639.1
32Select seq PF064808.1	KR 1020230065321-A/3: HA STEM VACCINE FOR HA ANTIBODY-POSITIVE TARGETS	synthetic construct	NA	32630	514	514	100%	2e-142	83.73%	927	PF064808.1
33Select seq PE392967.1	KR 1020230083266-A/72: COMPOSITIONS AND METHODS FOR IMPROVED VACCINATION	synthetic construct	NA	32630	459	459	100%	9e-126	81.95%	798	PE392967.1
34Select seq MP871160.1	Sequence 260 from Patent WO2020163719	synthetic construct	NA	32630	359	528	97%	9e-96	82.31%	2208	MP871160.1
35Select seq MP871158.1	Sequence 258 from Patent WO2020163719	synthetic construct	NA	32630	359	528	97%	9e-96	82.31%	2208	MP871158.1
36Select seq MP871012.1	Sequence 112 from Patent WO2020163719	synthetic construct	NA	32630	359	528	97%	9e-96	82.31%	1923	MP871012.1
37Select seq MP871010.1	Sequence 110 from Patent WO2020163719	synthetic construct	NA	32630	359	528	97%	9e-96	82.31%	1923	MP871010.1
38Select seq MP871008.1	Sequence 108 from Patent WO2020163719	synthetic construct	NA	32630	359	528	97%	9e-96	82.31%	1923	MP871008.1
39Select seq MP871006.1	Sequence 106 from Patent WO2020163719	synthetic construct	NA	32630	359	528	97%	9e-96	82.31%	1923	MP871006.1
40Select seq MP871004.1	Sequence 104 from Patent WO2020163719	synthetic construct	NA	32630	359	528	97%	9e-96	82.31%	1923	MP871004.1
41Select seq MP871002.1	Sequence 102 from Patent WO2020163719	synthetic construct	NA	32630	359	528	97%	9e-96	82.31%	1923	MP871002.1
42Select seq MP871000.1	Sequence 100 from Patent WO2020163719	synthetic construct	NA	32630	359	528	97%	9e-96	82.31%	1935	MP871000.1
43Select seq MP870998.1	Sequence 98 from Patent WO2020163719	synthetic construct	NA	32630	359	528	97%	9e-96	82.31%	1935	MP870998.1
44Select seq MP870996.1	Sequence 96 from Patent WO2020163719	synthetic construct	NA	32630	359	528	97%	9e-96	82.31%	1935	MP870996.1
45Select seq MP870994.1	Sequence 94 from Patent WO2020163719	synthetic construct	NA	32630	359	528	97%	9e-96	82.31%	1935	MP870994.1
46Select seq MP870992.1	Sequence 92 from Patent WO2020163719	synthetic construct	NA	32630	359	528	97%	9e-96	82.31%	1932	MP870992.1
47Select seq MP870990.1	Sequence 90 from Patent WO2020163719	synthetic construct	NA	32630	359	528	97%	9e-96	82.31%	1917	MP870990.1
48Select seq MQ124886.1	Sequence 105 from Patent EP3852799	synthetic construct	NA	32630	357	357	79%	3e-95	81.74%	1698	MQ124886.1
49Select seq MQ124896.1	Sequence 115 from Patent EP3852799	synthetic construct	NA	32630	342	462	97%	9e-91	81.52%	1698	MQ124896.1
50Select seq PB321627.1	JP 2020504764-A/134771: mRNA vaccines	synthetic construct	NA	32630	324	449	100%	3e-85	80.41%	1701	PB321627.1
51Select seq PB321058.1	JP 2020504764-A/134202: mRNA vaccines	synthetic construct	NA	32630	324	449	100%	3e-85	80.41%	1701	PB321058.1
52Select seq PB320662.1	JP 2020504764-A/133806: mRNA vaccines	synthetic construct	NA	32630	324	449	100%	3e-85	80.37%	1701	PB320662.1
53Select seq PB320514.1	JP 2020504764-A/133658: mRNA vaccines	synthetic construct	NA	32630	324	449	100%	3e-85	80.41%	1701	PB320514.1
54Select seq PB322648.1	JP 2020504764-A/135792: mRNA vaccines	synthetic construct	NA	32630	324	449	100%	3e-85	80.41%	1701	PB322648.1
55Select seq PB321797.1	JP 2020504764-A/134941: mRNA vaccines	synthetic construct	NA	32630	324	449	100%	3e-85	80.41%	1701	PB321797.1
56Select seq PB326788.1	JP 2020504764-A/139932: mRNA vaccines	synthetic construct	NA	32630	318	443	100%	2e-83	80.18%	1701	PB326788.1
57Select seq PB326783.1	JP 2020504764-A/139927: mRNA vaccines	synthetic construct	NA	32630	318	443	100%	2e-83	80.18%	1701	PB326783.1
58Select seq PB326782.1	JP 2020504764-A/139926: mRNA vaccines	synthetic construct	NA	32630	318	443	100%	2e-83	80.18%	1701	PB326782.1
59Select seq PB326781.1	JP 2020504764-A/139925: mRNA vaccines	synthetic construct	NA	32630	318	443	100%	2e-83	80.18%	1701	PB326781.1
60Select seq PB326778.1	JP 2020504764-A/139922: mRNA vaccines	synthetic construct	NA	32630	318	443	100%	2e-83	80.18%	1701	PB326778.1
61Select seq PB326037.1	JP 2020504764-A/139181: mRNA vaccines	synthetic construct	NA	32630	318	318	79%	2e-83	80.18%	1701	PB326037.1
62Select seq PB326035.1	JP 2020504764-A/139179: mRNA vaccines	synthetic construct	NA	32630	318	443	100%	2e-83	80.18%	1710	PB326035.1
63Select seq PB325989.1	JP 2020504764-A/139133: mRNA vaccines	synthetic construct	NA	32630	318	443	100%	2e-83	80.18%	1701	PB325989.1
64Select seq PB325927.1	JP 2020504764-A/139071: mRNA vaccines	synthetic construct	NA	32630	318	443	100%	2e-83	80.18%	1701	PB325927.1
65Select seq PB324742.1	JP 2020504764-A/137886: mRNA vaccines	synthetic construct	NA	32630	318	438	100%	2e-83	80.18%	1701	PB324742.1
66Select seq PB324741.1	JP 2020504764-A/137885: mRNA vaccines	synthetic construct	NA	32630	318	438	100%	2e-83	80.18%	1701	PB324741.1
67Select seq PB324694.1	JP 2020504764-A/137838: mRNA vaccines	synthetic construct	NA	32630	318	443	100%	2e-83	80.18%	1701	PB324694.1
68Select seq PB324691.1	JP 2020504764-A/137835: mRNA vaccines	synthetic construct	NA	32630	318	441	99%	2e-83	80.18%	1701	PB324691.1
69Select seq PB324668.1	JP 2020504764-A/137812: mRNA vaccines	synthetic construct	NA	32630	318	443	100%	2e-83	80.18%	1701	PB324668.1
70Select seq PB324660.1	JP 2020504764-A/137804: mRNA vaccines	synthetic construct	NA	32630	318	432	100%	2e-83	80.18%	1701	PB324660.1
71Select seq PB324658.1	JP 2020504764-A/137802: mRNA vaccines	synthetic construct	NA	32630	318	443	100%	2e-83	80.18%	1701	PB324658.1
72Select seq PB324655.1	JP 2020504764-A/137799: mRNA vaccines	synthetic construct	NA	32630	318	443	100%	2e-83	80.18%	1701	PB324655.1
73Select seq PB324648.1	JP 2020504764-A/137792: mRNA vaccines	synthetic construct	NA	32630	318	318	79%	2e-83	80.18%	1701	PB324648.1
74Select seq PB324647.1	JP 2020504764-A/137791: mRNA vaccines	synthetic construct	NA	32630	318	443	100%	2e-83	80.18%	1701	PB324647.1
75Select seq PB324645.1	JP 2020504764-A/137789: mRNA vaccines	synthetic construct	NA	32630	318	318	79%	2e-83	80.18%	1701	PB324645.1
76Select seq PB324640.1	JP 2020504764-A/137784: mRNA vaccines	synthetic construct	NA	32630	318	443	100%	2e-83	80.18%	1701	PB324640.1
77Select seq PB324639.1	JP 2020504764-A/137783: mRNA vaccines	synthetic construct	NA	32630	318	443	100%	2e-83	80.18%	1701	PB324639.1
78Select seq PB324638.1	JP 2020504764-A/137782: mRNA vaccines	synthetic construct	NA	32630	318	443	100%	2e-83	80.18%	1701	PB324638.1
79Select seq PB324635.1	JP 2020504764-A/137779: mRNA vaccines	synthetic construct	NA	32630	318	443	100%	2e-83	80.18%	1701	PB324635.1
80Select seq PB324632.1	JP 2020504764-A/137776: mRNA vaccines	synthetic construct	NA	32630	318	443	100%	2e-83	80.18%	1701	PB324632.1
81Select seq PB324621.1	JP 2020504764-A/137765: mRNA vaccines	synthetic construct	NA	32630	318	443	100%	2e-83	80.18%	1701	PB324621.1
82Select seq PB324609.1	JP 2020504764-A/137753: mRNA vaccines	synthetic construct	NA	32630	318	443	100%	2e-83	80.18%	1701	PB324609.1
83Select seq PB324579.1	JP 2020504764-A/137723: mRNA vaccines	synthetic construct	NA	32630	318	432	100%	2e-83	80.18%	1701	PB324579.1
84Select seq PB324573.1	JP 2020504764-A/137717: mRNA vaccines	synthetic construct	NA	32630	318	415	100%	2e-83	80.18%	1701	PB324573.1
85Select seq PB324533.1	JP 2020504764-A/137677: mRNA vaccines	synthetic construct	NA	32630	318	443	100%	2e-83	80.18%	1701	PB324533.1
86Select seq PB324532.1	JP 2020504764-A/137676: mRNA vaccines	synthetic construct	NA	32630	318	432	100%	2e-83	80.18%	1701	PB324532.1
87Select seq PB324527.1	JP 2020504764-A/137671: mRNA vaccines	synthetic construct	NA	32630	318	443	100%	2e-83	80.18%	1701	PB324527.1
88Select seq PB324526.1	JP 2020504764-A/137670: mRNA vaccines	synthetic construct	NA	32630	318	443	100%	2e-83	80.18%	1701	PB324526.1
89Select seq PB324525.1	JP 2020504764-A/137669: mRNA vaccines	synthetic construct	NA	32630	318	443	100%	2e-83	80.18%	1701	PB324525.1
90Select seq PB324524.1	JP 2020504764-A/137668: mRNA vaccines	synthetic construct	NA	32630	318	443	100%	2e-83	80.18%	1701	PB324524.1
91Select seq PB324520.1	JP 2020504764-A/137664: mRNA vaccines	synthetic construct	NA	32630	318	443	100%	2e-83	80.18%	1701	PB324520.1
92Select seq PB324477.1	JP 2020504764-A/137621: mRNA vaccines	synthetic construct	NA	32630	318	443	100%	2e-83	80.18%	1701	PB324477.1
93Select seq PB322537.1	JP 2020504764-A/135681: mRNA vaccines	synthetic construct	NA	32630	318	443	100%	2e-83	80.18%	1701	PB322537.1
94Select seq PB322517.1	JP 2020504764-A/135661: mRNA vaccines	synthetic construct	NA	32630	318	443	100%	2e-83	80.18%	1701	PB322517.1
95Select seq PB322512.1	JP 2020504764-A/135656: mRNA vaccines	synthetic construct	NA	32630	318	438	100%	2e-83	80.18%	1701	PB322512.1
96Select seq PB322508.1	JP 2020504764-A/135652: mRNA vaccines	synthetic construct	NA	32630	318	432	100%	2e-83	80.18%	1701	PB322508.1
97Select seq PB322505.1	JP 2020504764-A/135649: mRNA vaccines	synthetic construct	NA	32630	318	443	100%	2e-83	80.18%	1701	PB322505.1
98Select seq PB322499.1	JP 2020504764-A/135643: mRNA vaccines	synthetic construct	NA	32630	318	443	100%	2e-83	80.18%	1701	PB322499.1
99Select seq PB322497.1	JP 2020504764-A/135641: mRNA vaccines	synthetic construct	NA	32630	318	443	100%	2e-83	80.18%	1701	PB322497.1
100Select seq PB322493.1	JP 2020504764-A/135637: mRNA vaccines	synthetic construct	NA	32630	318	432	100%	2e-83	80.18%	1701	PB322493.1

- hover to see the title
- click to show alignments
- Show Conserved Domains
- Alignment Scores
- < 40
- 40 - 50
- 50 - 80
- 80 - 200
- >= 200
- Help
  The graphic is an overview of the database sequences aligned to the query sequence. These are represented horizontal bars colored coded by score and showing the extent of the alignment on the query sequence. Separate aligned regions on the same database sequence are connected by a thin grey line. Mousing over an alignment shows the database sequence title. Clicking an alignment displays a box with more details about the alignment and link to the sequence alignment itself in the Alignments section of the report.
- 100 sequences selected
- Help
Distribution of the top 163 Blast Hits on 100 subject sequences

Query

1
100
200
300
400
500

Alignments

100 sequences selected
Help

Download GenBank Graphics Next Previous Descriptions

JP 2021511077-A/3: Influenza virus vaccines and uses thereof

Sequence ID: PA271536.1Length: 792Number of Matches: 1

Range 1: 48 to 592GenBank Graphics Next Match Previous Match

Alignment statistics for match #1
Score	Expect	Identities	Gaps	Strand	Frame
1007 bits(545)	0.0()	545/545(100%)	0/545(0%)	Plus/Minus

Query  1    CCTTCTCATACAGATTCTTCACGTTGCTGTCGTGGTAGTCCAGGGTCCGCTGATTCTCGA  60
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  592  CCTTCTCATACAGATTCTTCACGTTGCTGTCGTGGTAGTCCAGGGTCCGCTGATTCTCGA  533

Query  61   GCAGCACCAGCAGCTCGGCGTTATAGCACCAGATCTTAGACTCGATCTCCTCGATCTTGT  120
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  532  GCAGCACCAGCAGCTCGGCGTTATAGCACCAGATCTTAGACTCGATCTCCTCGATCTTGT  473

Query  121  CCTCGATCTGCTTCATGCACCTCTCGGACTTATTGTACTCGCAGCCGATGGCTGTCCGCT  180
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  472  CCTCGATCTGCTTCATGCACCTCTCGGACTTATTGTACTCGCAGCCGATGGCTGTCCGCT  413

Query  181  GGGTGTTCATCTTCTCGATCACGCTATTGACCTTGTTTGTGATCTCATCAATGGCATTCT  240
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  412  GGGTGTTCATCTTCTCGATCACGCTATTGACCTTGTTTGTGATCTCATCAATGGCATTCT  353

Query  241  GGGTAGACTTCAGGTCAGCAGCATATCCAGATCCCTGCTCATTCTGGTGGTGATAGCCGT  300
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  352  GGGTAGACTTCAGGTCAGCAGCATATCCAGATCCCTGCTCATTCTGGTGGTGATAGCCGT  293

Query  301  ACCAGCCATCCACCATGCCTGTCCAGCCGCCCTCGGTAAAGCCTGCAATTGCTCCAAACA  360
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  292  ACCAGCCATCCACCATGCCTGTCCAGCCGCCCTCGGTAAAGCCTGCAATTGCTCCAAACA  233

Query  361  GGCCCTGGCTCTGCTTGCTGGGCTTGTTTCTCAGGCCTGTGGCCAGCCTCAGCTTGGTGC  420
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  232  GGCCCTGGCTCTGCTTGCTGGGCTTGTTTCTCAGGCCTGTGGCCAGCCTCAGCTTGGTGC  173

Query  421  TGCAGACGTACTTCTTATCCTCCAGCAGATTCACAGAGTGTGTCACGGTCACGTTCTTCT  480
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  172  TGCAGACGTACTTCTTATCCTCCAGCAGATTCACAGAGTGTGTCACGGTCACGTTCTTCT  113

Query  481  CCAGCACGGTATCCACTGTGTCGGTAGAGTTGTTAGCGTGGTACCCGATGCACAGGGTAT  540
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  112  CCAGCACGGTATCCACTGTGTCGGTAGAGTTGTTAGCGTGGTACCCGATGCACAGGGTAT  53

Query  541  CAGCG  545
            |||||
Sbjct  52   CAGCG  48

Download GenBank Graphics Next Previous Descriptions

KR 1020200113226-A/140: INFLUENZA VIRUS VACCINES AND USES THEREOF

Sequence ID: OF092927.1Length: 792Number of Matches: 1

Range 1: 48 to 592GenBank Graphics Next Match Previous Match

Alignment statistics for match #1
Score	Expect	Identities	Gaps	Strand	Frame
1007 bits(545)	0.0()	545/545(100%)	0/545(0%)	Plus/Minus

Query  1    CCTTCTCATACAGATTCTTCACGTTGCTGTCGTGGTAGTCCAGGGTCCGCTGATTCTCGA  60
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  592  CCTTCTCATACAGATTCTTCACGTTGCTGTCGTGGTAGTCCAGGGTCCGCTGATTCTCGA  533

Query  61   GCAGCACCAGCAGCTCGGCGTTATAGCACCAGATCTTAGACTCGATCTCCTCGATCTTGT  120
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  532  GCAGCACCAGCAGCTCGGCGTTATAGCACCAGATCTTAGACTCGATCTCCTCGATCTTGT  473

Query  121  CCTCGATCTGCTTCATGCACCTCTCGGACTTATTGTACTCGCAGCCGATGGCTGTCCGCT  180
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  472  CCTCGATCTGCTTCATGCACCTCTCGGACTTATTGTACTCGCAGCCGATGGCTGTCCGCT  413

Query  181  GGGTGTTCATCTTCTCGATCACGCTATTGACCTTGTTTGTGATCTCATCAATGGCATTCT  240
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  412  GGGTGTTCATCTTCTCGATCACGCTATTGACCTTGTTTGTGATCTCATCAATGGCATTCT  353

Query  241  GGGTAGACTTCAGGTCAGCAGCATATCCAGATCCCTGCTCATTCTGGTGGTGATAGCCGT  300
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  352  GGGTAGACTTCAGGTCAGCAGCATATCCAGATCCCTGCTCATTCTGGTGGTGATAGCCGT  293

Query  301  ACCAGCCATCCACCATGCCTGTCCAGCCGCCCTCGGTAAAGCCTGCAATTGCTCCAAACA  360
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  292  ACCAGCCATCCACCATGCCTGTCCAGCCGCCCTCGGTAAAGCCTGCAATTGCTCCAAACA  233

Query  361  GGCCCTGGCTCTGCTTGCTGGGCTTGTTTCTCAGGCCTGTGGCCAGCCTCAGCTTGGTGC  420
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  232  GGCCCTGGCTCTGCTTGCTGGGCTTGTTTCTCAGGCCTGTGGCCAGCCTCAGCTTGGTGC  173

Query  421  TGCAGACGTACTTCTTATCCTCCAGCAGATTCACAGAGTGTGTCACGGTCACGTTCTTCT  480
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  172  TGCAGACGTACTTCTTATCCTCCAGCAGATTCACAGAGTGTGTCACGGTCACGTTCTTCT  113

Query  481  CCAGCACGGTATCCACTGTGTCGGTAGAGTTGTTAGCGTGGTACCCGATGCACAGGGTAT  540
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  112  CCAGCACGGTATCCACTGTGTCGGTAGAGTTGTTAGCGTGGTACCCGATGCACAGGGTAT  53

Query  541  CAGCG  545
            |||||
Sbjct  52   CAGCG  48

Download GenBank Graphics Next Previous Descriptions

Sequence 140 from Patent WO2019145310

Sequence ID: MP222602.1Length: 792Number of Matches: 1

See 1 more title(s) See all Identical Proteins(IPG)

Range 1: 48 to 592GenBank Graphics Next Match Previous Match

Alignment statistics for match #1
Score	Expect	Identities	Gaps	Strand	Frame
1007 bits(545)	0.0()	545/545(100%)	0/545(0%)	Plus/Minus

Query  1    CCTTCTCATACAGATTCTTCACGTTGCTGTCGTGGTAGTCCAGGGTCCGCTGATTCTCGA  60
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  592  CCTTCTCATACAGATTCTTCACGTTGCTGTCGTGGTAGTCCAGGGTCCGCTGATTCTCGA  533

Query  61   GCAGCACCAGCAGCTCGGCGTTATAGCACCAGATCTTAGACTCGATCTCCTCGATCTTGT  120
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  532  GCAGCACCAGCAGCTCGGCGTTATAGCACCAGATCTTAGACTCGATCTCCTCGATCTTGT  473

Query  121  CCTCGATCTGCTTCATGCACCTCTCGGACTTATTGTACTCGCAGCCGATGGCTGTCCGCT  180
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  472  CCTCGATCTGCTTCATGCACCTCTCGGACTTATTGTACTCGCAGCCGATGGCTGTCCGCT  413

Query  181  GGGTGTTCATCTTCTCGATCACGCTATTGACCTTGTTTGTGATCTCATCAATGGCATTCT  240
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  412  GGGTGTTCATCTTCTCGATCACGCTATTGACCTTGTTTGTGATCTCATCAATGGCATTCT  353

Query  241  GGGTAGACTTCAGGTCAGCAGCATATCCAGATCCCTGCTCATTCTGGTGGTGATAGCCGT  300
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  352  GGGTAGACTTCAGGTCAGCAGCATATCCAGATCCCTGCTCATTCTGGTGGTGATAGCCGT  293

Query  301  ACCAGCCATCCACCATGCCTGTCCAGCCGCCCTCGGTAAAGCCTGCAATTGCTCCAAACA  360
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  292  ACCAGCCATCCACCATGCCTGTCCAGCCGCCCTCGGTAAAGCCTGCAATTGCTCCAAACA  233

Query  361  GGCCCTGGCTCTGCTTGCTGGGCTTGTTTCTCAGGCCTGTGGCCAGCCTCAGCTTGGTGC  420
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  232  GGCCCTGGCTCTGCTTGCTGGGCTTGTTTCTCAGGCCTGTGGCCAGCCTCAGCTTGGTGC  173

Query  421  TGCAGACGTACTTCTTATCCTCCAGCAGATTCACAGAGTGTGTCACGGTCACGTTCTTCT  480
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  172  TGCAGACGTACTTCTTATCCTCCAGCAGATTCACAGAGTGTGTCACGGTCACGTTCTTCT  113

Query  481  CCAGCACGGTATCCACTGTGTCGGTAGAGTTGTTAGCGTGGTACCCGATGCACAGGGTAT  540
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  112  CCAGCACGGTATCCACTGTGTCGGTAGAGTTGTTAGCGTGGTACCCGATGCACAGGGTAT  53

Query  541  CAGCG  545
            |||||
Sbjct  52   CAGCG  48

Download GenBank Graphics Next Previous Descriptions

JP 2021511077-A/4: Influenza virus vaccines and uses thereof

Sequence ID: PA271537.1Length: 792Number of Matches: 1

Range 1: 48 to 592GenBank Graphics Next Match Previous Match

Alignment statistics for match #1
Score	Expect	Identities	Gaps	Strand	Frame
996 bits(539)	0.0()	543/545(99%)	0/545(0%)	Plus/Minus

Query  1    CCTTCTCATACAGATTCTTCACGTTGCTGTCGTGGTAGTCCAGGGTCCGCTGATTCTCGA  60
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  592  CCTTCTCATACAGATTCTTCACGTTGCTGTCGTGGTAGTCCAGGGTCCGCTGATTCTCGA  533

Query  61   GCAGCACCAGCAGCTCGGCGTTATAGCACCAGATCTTAGACTCGATCTCCTCGATCTTGT  120
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  532  GCAGCACCAGCAGCTCGGCGTTATAGCACCAGATCTTAGACTCGATCTCCTCGATCTTGT  473

Query  121  CCTCGATCTGCTTCATGCACCTCTCGGACTTATTGTACTCGCAGCCGATGGCTGTCCGCT  180
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||  |||
Sbjct  472  CCTCGATCTGCTTCATGCACCTCTCGGACTTATTGTACTCGCAGCCGATGGCTGTAGGCT  413

Query  181  GGGTGTTCATCTTCTCGATCACGCTATTGACCTTGTTTGTGATCTCATCAATGGCATTCT  240
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  412  GGGTGTTCATCTTCTCGATCACGCTATTGACCTTGTTTGTGATCTCATCAATGGCATTCT  353

Query  241  GGGTAGACTTCAGGTCAGCAGCATATCCAGATCCCTGCTCATTCTGGTGGTGATAGCCGT  300
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  352  GGGTAGACTTCAGGTCAGCAGCATATCCAGATCCCTGCTCATTCTGGTGGTGATAGCCGT  293

Query  301  ACCAGCCATCCACCATGCCTGTCCAGCCGCCCTCGGTAAAGCCTGCAATTGCTCCAAACA  360
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  292  ACCAGCCATCCACCATGCCTGTCCAGCCGCCCTCGGTAAAGCCTGCAATTGCTCCAAACA  233

Query  361  GGCCCTGGCTCTGCTTGCTGGGCTTGTTTCTCAGGCCTGTGGCCAGCCTCAGCTTGGTGC  420
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  232  GGCCCTGGCTCTGCTTGCTGGGCTTGTTTCTCAGGCCTGTGGCCAGCCTCAGCTTGGTGC  173

Query  421  TGCAGACGTACTTCTTATCCTCCAGCAGATTCACAGAGTGTGTCACGGTCACGTTCTTCT  480
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  172  TGCAGACGTACTTCTTATCCTCCAGCAGATTCACAGAGTGTGTCACGGTCACGTTCTTCT  113

Query  481  CCAGCACGGTATCCACTGTGTCGGTAGAGTTGTTAGCGTGGTACCCGATGCACAGGGTAT  540
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  112  CCAGCACGGTATCCACTGTGTCGGTAGAGTTGTTAGCGTGGTACCCGATGCACAGGGTAT  53

Query  541  CAGCG  545
            |||||
Sbjct  52   CAGCG  48

Download GenBank Graphics Next Previous Descriptions

KR 1020200113226-A/141: INFLUENZA VIRUS VACCINES AND USES THEREOF

Sequence ID: OF092928.1Length: 792Number of Matches: 1

Range 1: 48 to 592GenBank Graphics Next Match Previous Match

Alignment statistics for match #1
Score	Expect	Identities	Gaps	Strand	Frame
996 bits(539)	0.0()	543/545(99%)	0/545(0%)	Plus/Minus

Query  1    CCTTCTCATACAGATTCTTCACGTTGCTGTCGTGGTAGTCCAGGGTCCGCTGATTCTCGA  60
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  592  CCTTCTCATACAGATTCTTCACGTTGCTGTCGTGGTAGTCCAGGGTCCGCTGATTCTCGA  533

Query  61   GCAGCACCAGCAGCTCGGCGTTATAGCACCAGATCTTAGACTCGATCTCCTCGATCTTGT  120
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  532  GCAGCACCAGCAGCTCGGCGTTATAGCACCAGATCTTAGACTCGATCTCCTCGATCTTGT  473

Query  121  CCTCGATCTGCTTCATGCACCTCTCGGACTTATTGTACTCGCAGCCGATGGCTGTCCGCT  180
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||  |||
Sbjct  472  CCTCGATCTGCTTCATGCACCTCTCGGACTTATTGTACTCGCAGCCGATGGCTGTAGGCT  413

Query  181  GGGTGTTCATCTTCTCGATCACGCTATTGACCTTGTTTGTGATCTCATCAATGGCATTCT  240
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  412  GGGTGTTCATCTTCTCGATCACGCTATTGACCTTGTTTGTGATCTCATCAATGGCATTCT  353

Query  241  GGGTAGACTTCAGGTCAGCAGCATATCCAGATCCCTGCTCATTCTGGTGGTGATAGCCGT  300
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  352  GGGTAGACTTCAGGTCAGCAGCATATCCAGATCCCTGCTCATTCTGGTGGTGATAGCCGT  293

Query  301  ACCAGCCATCCACCATGCCTGTCCAGCCGCCCTCGGTAAAGCCTGCAATTGCTCCAAACA  360
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  292  ACCAGCCATCCACCATGCCTGTCCAGCCGCCCTCGGTAAAGCCTGCAATTGCTCCAAACA  233

Query  361  GGCCCTGGCTCTGCTTGCTGGGCTTGTTTCTCAGGCCTGTGGCCAGCCTCAGCTTGGTGC  420
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  232  GGCCCTGGCTCTGCTTGCTGGGCTTGTTTCTCAGGCCTGTGGCCAGCCTCAGCTTGGTGC  173

Query  421  TGCAGACGTACTTCTTATCCTCCAGCAGATTCACAGAGTGTGTCACGGTCACGTTCTTCT  480
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  172  TGCAGACGTACTTCTTATCCTCCAGCAGATTCACAGAGTGTGTCACGGTCACGTTCTTCT  113

Query  481  CCAGCACGGTATCCACTGTGTCGGTAGAGTTGTTAGCGTGGTACCCGATGCACAGGGTAT  540
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  112  CCAGCACGGTATCCACTGTGTCGGTAGAGTTGTTAGCGTGGTACCCGATGCACAGGGTAT  53

Query  541  CAGCG  545
            |||||
Sbjct  52   CAGCG  48

Download GenBank Graphics Next Previous Descriptions

Sequence 141 from Patent WO2019145310

Sequence ID: MP222603.1Length: 792Number of Matches: 1

See 1 more title(s) See all Identical Proteins(IPG)

Range 1: 48 to 592GenBank Graphics Next Match Previous Match

Alignment statistics for match #1
Score	Expect	Identities	Gaps	Strand	Frame
996 bits(539)	0.0()	543/545(99%)	0/545(0%)	Plus/Minus

Query  1    CCTTCTCATACAGATTCTTCACGTTGCTGTCGTGGTAGTCCAGGGTCCGCTGATTCTCGA  60
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  592  CCTTCTCATACAGATTCTTCACGTTGCTGTCGTGGTAGTCCAGGGTCCGCTGATTCTCGA  533

Query  61   GCAGCACCAGCAGCTCGGCGTTATAGCACCAGATCTTAGACTCGATCTCCTCGATCTTGT  120
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  532  GCAGCACCAGCAGCTCGGCGTTATAGCACCAGATCTTAGACTCGATCTCCTCGATCTTGT  473

Query  121  CCTCGATCTGCTTCATGCACCTCTCGGACTTATTGTACTCGCAGCCGATGGCTGTCCGCT  180
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||  |||
Sbjct  472  CCTCGATCTGCTTCATGCACCTCTCGGACTTATTGTACTCGCAGCCGATGGCTGTAGGCT  413

Query  181  GGGTGTTCATCTTCTCGATCACGCTATTGACCTTGTTTGTGATCTCATCAATGGCATTCT  240
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  412  GGGTGTTCATCTTCTCGATCACGCTATTGACCTTGTTTGTGATCTCATCAATGGCATTCT  353

Query  241  GGGTAGACTTCAGGTCAGCAGCATATCCAGATCCCTGCTCATTCTGGTGGTGATAGCCGT  300
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  352  GGGTAGACTTCAGGTCAGCAGCATATCCAGATCCCTGCTCATTCTGGTGGTGATAGCCGT  293

Query  301  ACCAGCCATCCACCATGCCTGTCCAGCCGCCCTCGGTAAAGCCTGCAATTGCTCCAAACA  360
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  292  ACCAGCCATCCACCATGCCTGTCCAGCCGCCCTCGGTAAAGCCTGCAATTGCTCCAAACA  233

Query  361  GGCCCTGGCTCTGCTTGCTGGGCTTGTTTCTCAGGCCTGTGGCCAGCCTCAGCTTGGTGC  420
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  232  GGCCCTGGCTCTGCTTGCTGGGCTTGTTTCTCAGGCCTGTGGCCAGCCTCAGCTTGGTGC  173

Query  421  TGCAGACGTACTTCTTATCCTCCAGCAGATTCACAGAGTGTGTCACGGTCACGTTCTTCT  480
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  172  TGCAGACGTACTTCTTATCCTCCAGCAGATTCACAGAGTGTGTCACGGTCACGTTCTTCT  113

Query  481  CCAGCACGGTATCCACTGTGTCGGTAGAGTTGTTAGCGTGGTACCCGATGCACAGGGTAT  540
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  112  CCAGCACGGTATCCACTGTGTCGGTAGAGTTGTTAGCGTGGTACCCGATGCACAGGGTAT  53

Query  541  CAGCG  545
            |||||
Sbjct  52   CAGCG  48

Download GenBank Graphics Next Previous Descriptions

JP 2021511077-A/7: Influenza virus vaccines and uses thereof

Sequence ID: PA271540.1Length: 900Number of Matches: 1

Range 1: 48 to 592GenBank Graphics Next Match Previous Match

Alignment statistics for match #1
Score	Expect	Identities	Gaps	Strand	Frame
846 bits(458)	0.0()	516/545(95%)	0/545(0%)	Plus/Minus

Query  1    CCTTCTCATACAGATTCTTCACGTTGCTGTCGTGGTAGTCCAGGGTCCGCTGATTCTCGA  60
            |||||||||||||||||||||||||||| ||||||||||||||||||| ||||||||| |
Sbjct  592  CCTTCTCATACAGATTCTTCACGTTGCTATCGTGGTAGTCCAGGGTCCTCTGATTCTCCA  533

Query  61   GCAGCACCAGCAGCTCGGCGTTATAGCACCAGATCTTAGACTCGATCTCCTCGATCTTGT  120
            ||||||||||||||||||||||||||||||||||||| ||||||||||||||||||||||
Sbjct  532  GCAGCACCAGCAGCTCGGCGTTATAGCACCAGATCTTGGACTCGATCTCCTCGATCTTGT  473

Query  121  CCTCGATCTGCTTCATGCACCTCTCGGACTTATTGTACTCGCAGCCGATGGCTGTCCGCT  180
            |||||||||||||||| |||||||||  ||||||||||||||||||||||||||||| ||
Sbjct  472  CCTCGATCTGCTTCATACACCTCTCGCTCTTATTGTACTCGCAGCCGATGGCTGTCCTCT  413

Query  181  GGGTGTTCATCTTCTCGATCACGCTATTGACCTTGTTTGTGATCTCATCAATGGCATTCT  240
            ||||||||||||||||||||||   ||||||||||||||||||||| || ||||||||||
Sbjct  412  GGGTGTTCATCTTCTCGATCACAGAATTGACCTTGTTTGTGATCTCGTCGATGGCATTCT  353

Query  241  GGGTAGACTTCAGGTCAGCAGCATATCCAGATCCCTGCTCATTCTGGTGGTGATAGCCGT  300
            |||||||||||||||| || |||||||| ||||||||||| |||||||||||||||||||
Sbjct  352  GGGTAGACTTCAGGTCGGCGGCATATCCGGATCCCTGCTCGTTCTGGTGGTGATAGCCGT  293

Query  301  ACCAGCCATCCACCATGCCTGTCCAGCCGCCCTCGGTAAAGCCTGCAATTGCTCCAAACA  360
            ||||||||||||||||||||||||| || ||||||||||||||||| |||||||| ||||
Sbjct  292  ACCAGCCATCCACCATGCCTGTCCATCCTCCCTCGGTAAAGCCTGCGATTGCTCCGAACA  233

Query  361  GGCCCTGGCTCTGCTTGCTGGGCTTGTTTCTCAGGCCTGTGGCCAGCCTCAGCTTGGTGC  420
            ||||||||||||||||   |||||||||||||||||||||||||||||||||||||||||
Sbjct  232  GGCCCTGGCTCTGCTTAGAGGGCTTGTTTCTCAGGCCTGTGGCCAGCCTCAGCTTGGTGC  173

Query  421  TGCAGACGTACTTCTTATCCTCCAGCAGATTCACAGAGTGTGTCACGGTCACGTTCTTCT  480
            |||||||||||||||| |||||||||||||||||||||||||||||||||||||||||||
Sbjct  172  TGCAGACGTACTTCTTGTCCTCCAGCAGATTCACAGAGTGTGTCACGGTCACGTTCTTCT  113

Query  481  CCAGCACGGTATCCACTGTGTCGGTAGAGTTGTTAGCGTGGTACCCGATGCACAGGGTAT  540
            ||||||||||||||||||||||||| ||||| || ||||||||||||||||||||||| |
Sbjct  112  CCAGCACGGTATCCACTGTGTCGGTGGAGTTATTGGCGTGGTACCCGATGCACAGGGTGT  53

Query  541  CAGCG  545
            |||||
Sbjct  52   CAGCG  48

Download GenBank Graphics Next Previous Descriptions

KR 1020200113226-A/144: INFLUENZA VIRUS VACCINES AND USES THEREOF

Sequence ID: OF092931.1Length: 900Number of Matches: 1

Range 1: 48 to 592GenBank Graphics Next Match Previous Match

Alignment statistics for match #1
Score	Expect	Identities	Gaps	Strand	Frame
846 bits(458)	0.0()	516/545(95%)	0/545(0%)	Plus/Minus

Query  1    CCTTCTCATACAGATTCTTCACGTTGCTGTCGTGGTAGTCCAGGGTCCGCTGATTCTCGA  60
            |||||||||||||||||||||||||||| ||||||||||||||||||| ||||||||| |
Sbjct  592  CCTTCTCATACAGATTCTTCACGTTGCTATCGTGGTAGTCCAGGGTCCTCTGATTCTCCA  533

Query  61   GCAGCACCAGCAGCTCGGCGTTATAGCACCAGATCTTAGACTCGATCTCCTCGATCTTGT  120
            ||||||||||||||||||||||||||||||||||||| ||||||||||||||||||||||
Sbjct  532  GCAGCACCAGCAGCTCGGCGTTATAGCACCAGATCTTGGACTCGATCTCCTCGATCTTGT  473

Query  121  CCTCGATCTGCTTCATGCACCTCTCGGACTTATTGTACTCGCAGCCGATGGCTGTCCGCT  180
            |||||||||||||||| |||||||||  ||||||||||||||||||||||||||||| ||
Sbjct  472  CCTCGATCTGCTTCATACACCTCTCGCTCTTATTGTACTCGCAGCCGATGGCTGTCCTCT  413

Query  181  GGGTGTTCATCTTCTCGATCACGCTATTGACCTTGTTTGTGATCTCATCAATGGCATTCT  240
            ||||||||||||||||||||||   ||||||||||||||||||||| || ||||||||||
Sbjct  412  GGGTGTTCATCTTCTCGATCACAGAATTGACCTTGTTTGTGATCTCGTCGATGGCATTCT  353

Query  241  GGGTAGACTTCAGGTCAGCAGCATATCCAGATCCCTGCTCATTCTGGTGGTGATAGCCGT  300
            |||||||||||||||| || |||||||| ||||||||||| |||||||||||||||||||
Sbjct  352  GGGTAGACTTCAGGTCGGCGGCATATCCGGATCCCTGCTCGTTCTGGTGGTGATAGCCGT  293

Query  301  ACCAGCCATCCACCATGCCTGTCCAGCCGCCCTCGGTAAAGCCTGCAATTGCTCCAAACA  360
            ||||||||||||||||||||||||| || ||||||||||||||||| |||||||| ||||
Sbjct  292  ACCAGCCATCCACCATGCCTGTCCATCCTCCCTCGGTAAAGCCTGCGATTGCTCCGAACA  233

Query  361  GGCCCTGGCTCTGCTTGCTGGGCTTGTTTCTCAGGCCTGTGGCCAGCCTCAGCTTGGTGC  420
            ||||||||||||||||   |||||||||||||||||||||||||||||||||||||||||
Sbjct  232  GGCCCTGGCTCTGCTTAGAGGGCTTGTTTCTCAGGCCTGTGGCCAGCCTCAGCTTGGTGC  173

Query  421  TGCAGACGTACTTCTTATCCTCCAGCAGATTCACAGAGTGTGTCACGGTCACGTTCTTCT  480
            |||||||||||||||| |||||||||||||||||||||||||||||||||||||||||||
Sbjct  172  TGCAGACGTACTTCTTGTCCTCCAGCAGATTCACAGAGTGTGTCACGGTCACGTTCTTCT  113

Query  481  CCAGCACGGTATCCACTGTGTCGGTAGAGTTGTTAGCGTGGTACCCGATGCACAGGGTAT  540
            ||||||||||||||||||||||||| ||||| || ||||||||||||||||||||||| |
Sbjct  112  CCAGCACGGTATCCACTGTGTCGGTGGAGTTATTGGCGTGGTACCCGATGCACAGGGTGT  53

Query  541  CAGCG  545
            |||||
Sbjct  52   CAGCG  48

Download GenBank Graphics Next Previous Descriptions

Sequence 144 from Patent WO2019145310

Sequence ID: MP222606.1Length: 900Number of Matches: 1

See 1 more title(s) See all Identical Proteins(IPG)

Range 1: 48 to 592GenBank Graphics Next Match Previous Match

Alignment statistics for match #1
Score	Expect	Identities	Gaps	Strand	Frame
846 bits(458)	0.0()	516/545(95%)	0/545(0%)	Plus/Minus

Query  1    CCTTCTCATACAGATTCTTCACGTTGCTGTCGTGGTAGTCCAGGGTCCGCTGATTCTCGA  60
            |||||||||||||||||||||||||||| ||||||||||||||||||| ||||||||| |
Sbjct  592  CCTTCTCATACAGATTCTTCACGTTGCTATCGTGGTAGTCCAGGGTCCTCTGATTCTCCA  533

Query  61   GCAGCACCAGCAGCTCGGCGTTATAGCACCAGATCTTAGACTCGATCTCCTCGATCTTGT  120
            ||||||||||||||||||||||||||||||||||||| ||||||||||||||||||||||
Sbjct  532  GCAGCACCAGCAGCTCGGCGTTATAGCACCAGATCTTGGACTCGATCTCCTCGATCTTGT  473

Query  121  CCTCGATCTGCTTCATGCACCTCTCGGACTTATTGTACTCGCAGCCGATGGCTGTCCGCT  180
            |||||||||||||||| |||||||||  ||||||||||||||||||||||||||||| ||
Sbjct  472  CCTCGATCTGCTTCATACACCTCTCGCTCTTATTGTACTCGCAGCCGATGGCTGTCCTCT  413

Query  181  GGGTGTTCATCTTCTCGATCACGCTATTGACCTTGTTTGTGATCTCATCAATGGCATTCT  240
            ||||||||||||||||||||||   ||||||||||||||||||||| || ||||||||||
Sbjct  412  GGGTGTTCATCTTCTCGATCACAGAATTGACCTTGTTTGTGATCTCGTCGATGGCATTCT  353

Query  241  GGGTAGACTTCAGGTCAGCAGCATATCCAGATCCCTGCTCATTCTGGTGGTGATAGCCGT  300
            |||||||||||||||| || |||||||| ||||||||||| |||||||||||||||||||
Sbjct  352  GGGTAGACTTCAGGTCGGCGGCATATCCGGATCCCTGCTCGTTCTGGTGGTGATAGCCGT  293

Query  301  ACCAGCCATCCACCATGCCTGTCCAGCCGCCCTCGGTAAAGCCTGCAATTGCTCCAAACA  360
            ||||||||||||||||||||||||| || ||||||||||||||||| |||||||| ||||
Sbjct  292  ACCAGCCATCCACCATGCCTGTCCATCCTCCCTCGGTAAAGCCTGCGATTGCTCCGAACA  233

Query  361  GGCCCTGGCTCTGCTTGCTGGGCTTGTTTCTCAGGCCTGTGGCCAGCCTCAGCTTGGTGC  420
            ||||||||||||||||   |||||||||||||||||||||||||||||||||||||||||
Sbjct  232  GGCCCTGGCTCTGCTTAGAGGGCTTGTTTCTCAGGCCTGTGGCCAGCCTCAGCTTGGTGC  173

Query  421  TGCAGACGTACTTCTTATCCTCCAGCAGATTCACAGAGTGTGTCACGGTCACGTTCTTCT  480
            |||||||||||||||| |||||||||||||||||||||||||||||||||||||||||||
Sbjct  172  TGCAGACGTACTTCTTGTCCTCCAGCAGATTCACAGAGTGTGTCACGGTCACGTTCTTCT  113

Query  481  CCAGCACGGTATCCACTGTGTCGGTAGAGTTGTTAGCGTGGTACCCGATGCACAGGGTAT  540
            ||||||||||||||||||||||||| ||||| || ||||||||||||||||||||||| |
Sbjct  112  CCAGCACGGTATCCACTGTGTCGGTGGAGTTATTGGCGTGGTACCCGATGCACAGGGTGT  53

Query  541  CAGCG  545
            |||||
Sbjct  52   CAGCG  48

Download GenBank Graphics Next Previous Descriptions

JP 2021511077-A/8: Influenza virus vaccines and uses thereof

Sequence ID: PA271541.1Length: 900Number of Matches: 1

Range 1: 48 to 592GenBank Graphics Next Match Previous Match

Alignment statistics for match #1
Score	Expect	Identities	Gaps	Strand	Frame
841 bits(455)	0.0()	515/545(94%)	0/545(0%)	Plus/Minus

Query  1    CCTTCTCATACAGATTCTTCACGTTGCTGTCGTGGTAGTCCAGGGTCCGCTGATTCTCGA  60
            |||||||||||||||||||||||||||| ||||||||||||||||||| ||||||||| |
Sbjct  592  CCTTCTCATACAGATTCTTCACGTTGCTATCGTGGTAGTCCAGGGTCCTCTGATTCTCCA  533

Query  61   GCAGCACCAGCAGCTCGGCGTTATAGCACCAGATCTTAGACTCGATCTCCTCGATCTTGT  120
            ||||||||||||||||||||||||||||||||||||| ||||||||||||||||||||||
Sbjct  532  GCAGCACCAGCAGCTCGGCGTTATAGCACCAGATCTTGGACTCGATCTCCTCGATCTTGT  473

Query  121  CCTCGATCTGCTTCATGCACCTCTCGGACTTATTGTACTCGCAGCCGATGGCTGTCCGCT  180
            |||||||||||||||| |||||||||  |||||||||||||||||||||||||||  |||
Sbjct  472  CCTCGATCTGCTTCATACACCTCTCGCTCTTATTGTACTCGCAGCCGATGGCTGTAGGCT  413

Query  181  GGGTGTTCATCTTCTCGATCACGCTATTGACCTTGTTTGTGATCTCATCAATGGCATTCT  240
            ||||||||||||||||||||||   ||||||||||||||||||||| || ||||||||||
Sbjct  412  GGGTGTTCATCTTCTCGATCACAGAATTGACCTTGTTTGTGATCTCGTCGATGGCATTCT  353

Query  241  GGGTAGACTTCAGGTCAGCAGCATATCCAGATCCCTGCTCATTCTGGTGGTGATAGCCGT  300
            |||||||||||||||| || |||||||| ||||||||||| |||||||||||||||||||
Sbjct  352  GGGTAGACTTCAGGTCGGCGGCATATCCGGATCCCTGCTCGTTCTGGTGGTGATAGCCGT  293

Query  301  ACCAGCCATCCACCATGCCTGTCCAGCCGCCCTCGGTAAAGCCTGCAATTGCTCCAAACA  360
            ||||||||||||||||||||||||| || ||||||||||||||||| |||||||| ||||
Sbjct  292  ACCAGCCATCCACCATGCCTGTCCATCCTCCCTCGGTAAAGCCTGCGATTGCTCCGAACA  233

Query  361  GGCCCTGGCTCTGCTTGCTGGGCTTGTTTCTCAGGCCTGTGGCCAGCCTCAGCTTGGTGC  420
            ||||||||||||||||   |||||||||||||||||||||||||||||||||||||||||
Sbjct  232  GGCCCTGGCTCTGCTTAGAGGGCTTGTTTCTCAGGCCTGTGGCCAGCCTCAGCTTGGTGC  173

Query  421  TGCAGACGTACTTCTTATCCTCCAGCAGATTCACAGAGTGTGTCACGGTCACGTTCTTCT  480
            |||||||||||||||| |||||||||||||||||||||||||||||||||||||||||||
Sbjct  172  TGCAGACGTACTTCTTGTCCTCCAGCAGATTCACAGAGTGTGTCACGGTCACGTTCTTCT  113

Query  481  CCAGCACGGTATCCACTGTGTCGGTAGAGTTGTTAGCGTGGTACCCGATGCACAGGGTAT  540
            ||||||||||||||||||||||||| ||||| || ||||||||||||||||||||||| |
Sbjct  112  CCAGCACGGTATCCACTGTGTCGGTGGAGTTATTGGCGTGGTACCCGATGCACAGGGTGT  53

Query  541  CAGCG  545
            |||||
Sbjct  52   CAGCG  48

Taxonomy

100 sequences selected
Help

Lineage

Lineage Report
Organism	Blast Name	Score	Number of Hits	Description
root			104
.synthetic construct	other sequences	1007	102	synthetic construct hits
.unidentified influenza virus	viruses	562	2	unidentified influenza virus hits

Organism

Organism Report
Description	Score	E value	Accession
synthetic construct [other sequences] Next Previous First
JP 2021511077-A/3: Influenza virus vaccines and uses thereof	1007	0.0	PA271536
KR 1020200113226-A/140: INFLUENZA VIRUS VACCINES AND USES THEREOF	1007	0.0	OF092927
Sequence 140 from Patent WO2019145310	1007	0.0	MP222602
JP 2021511077-A/4: Influenza virus vaccines and uses thereof	996	0.0	PA271537
KR 1020200113226-A/141: INFLUENZA VIRUS VACCINES AND USES THEREOF	996	0.0	OF092928
Sequence 141 from Patent WO2019145310	996	0.0	MP222603
JP 2021511077-A/7: Influenza virus vaccines and uses thereof	846	0.0	PA271540
KR 1020200113226-A/144: INFLUENZA VIRUS VACCINES AND USES THEREOF	846	0.0	OF092931
Sequence 144 from Patent WO2019145310	846	0.0	MP222606
JP 2021511077-A/8: Influenza virus vaccines and uses thereof	841	0.0	PA271541
KR 1020200113226-A/145: INFLUENZA VIRUS VACCINES AND USES THEREOF	841	0.0	OF092932
Sequence 145 from Patent WO2019145310	841	0.0	MP222607
JP 2021511077-A/6: Influenza virus vaccines and uses thereof	819	0.0	PA271539
KR 1020200113226-A/143: INFLUENZA VIRUS VACCINES AND USES THEREOF	819	0.0	OF092930
Sequence 143 from Patent WO2019145310	819	0.0	MP222605
JP 2021511077-A/1: Influenza virus vaccines and uses thereof	736	0.0	PA271534
KR 1020200113226-A/138: INFLUENZA VIRUS VACCINES AND USES THEREOF	736	0.0	OF092925
Sequence 138 from Patent WO2019145310	736	0.0	MP222600
JP 2021511077-A/2: Influenza virus vaccines and uses thereof	725	0.0	PA271535
KR 1020200113226-A/139: INFLUENZA VIRUS VACCINES AND USES THEREOF	725	0.0	OF092926
Sequence 139 from Patent WO2019145310	725	0.0	MP222601
JP 2021511077-A/5: Influenza virus vaccines and uses thereof	664	0.0	PA271538
KR 1020200113226-A/142: INFLUENZA VIRUS VACCINES AND USES THEREOF	664	0.0	OF092929
Sequence 142 from Patent WO2019145310	664	0.0	MP222604
KR 1020230104068-A/28: UNIVERSAL INFLUENZA VACCINE USING NUCLEOSIDE-MODIFIELD MRNA	532	5e-148	PF151639
KR 1020230065321-A/3: HA STEM VACCINE FOR HA ANTIBODY-POSITIVE TARGETS	514	2e-142	PF064808
KR 1020230083266-A/72: COMPOSITIONS AND METHODS FOR IMPROVED VACCINATION	459	9e-126	PE392967
Sequence 260 from Patent WO2020163719	359	9e-96	MP871160
Sequence 258 from Patent WO2020163719	359	9e-96	MP871158
Sequence 112 from Patent WO2020163719	359	9e-96	MP871012
Sequence 110 from Patent WO2020163719	359	9e-96	MP871010
Sequence 108 from Patent WO2020163719	359	9e-96	MP871008
Sequence 106 from Patent WO2020163719	359	9e-96	MP871006
Sequence 104 from Patent WO2020163719	359	9e-96	MP871004
Sequence 102 from Patent WO2020163719	359	9e-96	MP871002
Sequence 100 from Patent WO2020163719	359	9e-96	MP871000
Sequence 98 from Patent WO2020163719	359	9e-96	MP870998
Sequence 96 from Patent WO2020163719	359	9e-96	MP870996
Sequence 94 from Patent WO2020163719	359	9e-96	MP870994
Sequence 92 from Patent WO2020163719	359	9e-96	MP870992
Sequence 90 from Patent WO2020163719	359	9e-96	MP870990
Sequence 105 from Patent EP3852799	357	3e-95	MQ124886
Sequence 115 from Patent EP3852799	342	9e-91	MQ124896
JP 2020504764-A/134771: mRNA vaccines	324	3e-85	PB321627
JP 2020504764-A/134202: mRNA vaccines	324	3e-85	PB321058
JP 2020504764-A/133806: mRNA vaccines	324	3e-85	PB320662
JP 2020504764-A/133658: mRNA vaccines	324	3e-85	PB320514
JP 2020504764-A/135792: mRNA vaccines	324	3e-85	PB322648
JP 2020504764-A/134941: mRNA vaccines	324	3e-85	PB321797
JP 2020504764-A/139932: mRNA vaccines	318	2e-83	PB326788
JP 2020504764-A/139927: mRNA vaccines	318	2e-83	PB326783
JP 2020504764-A/139928: mRNA vaccines	318	2e-83	PB326784
JP 2020504764-A/139929: mRNA vaccines	318	2e-83	PB326785
JP 2020504764-A/139930: mRNA vaccines	318	2e-83	PB326786
JP 2020504764-A/139931: mRNA vaccines	318	2e-83	PB326787
JP 2020504764-A/139926: mRNA vaccines	318	2e-83	PB326782
JP 2020504764-A/139925: mRNA vaccines	318	2e-83	PB326781
JP 2020504764-A/139922: mRNA vaccines	318	2e-83	PB326778
JP 2020504764-A/139923: mRNA vaccines	318	2e-83	PB326779
JP 2020504764-A/139924: mRNA vaccines	318	2e-83	PB326780
JP 2020504764-A/139181: mRNA vaccines	318	2e-83	PB326037
JP 2020504764-A/139179: mRNA vaccines	318	2e-83	PB326035
JP 2020504764-A/139133: mRNA vaccines	318	2e-83	PB325989
JP 2020504764-A/139071: mRNA vaccines	318	2e-83	PB325927
JP 2020504764-A/137886: mRNA vaccines	318	2e-83	PB324742
JP 2020504764-A/137885: mRNA vaccines	318	2e-83	PB324741
JP 2020504764-A/137898: mRNA vaccines	318	2e-83	PB324754
JP 2020504764-A/137838: mRNA vaccines	318	2e-83	PB324694
JP 2020504764-A/137835: mRNA vaccines	318	2e-83	PB324691
JP 2020504764-A/137812: mRNA vaccines	318	2e-83	PB324668
JP 2020504764-A/137804: mRNA vaccines	318	2e-83	PB324660
JP 2020504764-A/137802: mRNA vaccines	318	2e-83	PB324658
JP 2020504764-A/137799: mRNA vaccines	318	2e-83	PB324655
JP 2020504764-A/137792: mRNA vaccines	318	2e-83	PB324648
JP 2020504764-A/137791: mRNA vaccines	318	2e-83	PB324647
JP 2020504764-A/137789: mRNA vaccines	318	2e-83	PB324645
JP 2020504764-A/137784: mRNA vaccines	318	2e-83	PB324640
JP 2020504764-A/137783: mRNA vaccines	318	2e-83	PB324639
JP 2020504764-A/137782: mRNA vaccines	318	2e-83	PB324638
JP 2020504764-A/137800: mRNA vaccines	318	2e-83	PB324656
JP 2020504764-A/137779: mRNA vaccines	318	2e-83	PB324635
JP 2020504764-A/137776: mRNA vaccines	318	2e-83	PB324632
JP 2020504764-A/137765: mRNA vaccines	318	2e-83	PB324621
JP 2020504764-A/137753: mRNA vaccines	318	2e-83	PB324609
JP 2020504764-A/137723: mRNA vaccines	318	2e-83	PB324579
JP 2020504764-A/137717: mRNA vaccines	318	2e-83	PB324573
JP 2020504764-A/137677: mRNA vaccines	318	2e-83	PB324533
JP 2020504764-A/137676: mRNA vaccines	318	2e-83	PB324532
JP 2020504764-A/137671: mRNA vaccines	318	2e-83	PB324527
JP 2020504764-A/137670: mRNA vaccines	318	2e-83	PB324526
JP 2020504764-A/137669: mRNA vaccines	318	2e-83	PB324525
JP 2020504764-A/137668: mRNA vaccines	318	2e-83	PB324524
JP 2020504764-A/137664: mRNA vaccines	318	2e-83	PB324520
JP 2020504764-A/137621: mRNA vaccines	318	2e-83	PB324477
JP 2020504764-A/135681: mRNA vaccines	318	2e-83	PB322537
JP 2020504764-A/135661: mRNA vaccines	318	2e-83	PB322517
JP 2020504764-A/135656: mRNA vaccines	318	2e-83	PB322512
JP 2020504764-A/135652: mRNA vaccines	318	2e-83	PB322508
JP 2020504764-A/135649: mRNA vaccines	318	2e-83	PB322505
JP 2020504764-A/135643: mRNA vaccines	318	2e-83	PB322499
JP 2020504764-A/135641: mRNA vaccines	318	2e-83	PB322497
JP 2020504764-A/135637: mRNA vaccines	318	2e-83	PB322493
unidentified influenza virus [viruses] Next Previous First
Sequence 89 from Patent WO2016112921	562	6e-157	LQ465429
Sequence 17 from Patent WO2016112921	562	6e-157	LQ465357

Taxonomy

Taxonomy Report
Taxonomy	Number of hits	Number of Organisms	Description
root	104	2
. synthetic construct	102	1	synthetic construct hits
. unidentified influenza virus	2	1	unidentified influenza virus hits

Filter Results

Sequences producing significant alignments